PMRA.F 80.45 (+0.56%)
ES0169501022BiotechnologyBiotechnology

Pharma Mar (PMRA.F) Financial Metrics

This table shows a selected set of financial data points of Pharma Mar (PMRA.F). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2024 0 0.81 0 1.44B 0 0 0 0 0 0
2023 0.06 1.54 665.2 756.1M 0 158.15M -29.4M 4.08M 1.14M 60.02M
2022 2.73 1 23.77 1.17B 0.13 196.34M 29.47M 54.32M 49.36M 149.81M
2021 5.14 1.09 10.71 994.93M 0.27 229.83M 17.87M 103.98M 92.86M 113.35M
2020 7.5 0.66 9.66 1.33B 0.6 269.96M 275.94M 156.21M 137.26M 96.21M
2019 -0.62 0 -72.17 821.26M -0.08 85.82M -30.05M -11.44M -11.38M 17.64M
2018 -0.3 0 -44.17 244.46M -0.03 162.16M -18.72M -7.13M -5.54M 22.75M
2017 -1.45 0 -21.16 565.8M -0.13 179.34M -6.12M -10.68M -26.75M 24.09M
2016 0 0 0 0 -0.11 180.94M 0 0 -24.08M 14.29M
2015 0 0 0 0 0.03 193.82M 0 0 6.59M 7.63M
2014 0 0 0 0 0.03 150.42M 0 0 11.27M 14.24M
2013 0 0 0 0 0 74.35M 0 0 11.87M 9.67M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.